REVOLUTION MEDICINES
Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex chemicals of life by reconfiguring natural substances into best-in-class medicines. REVOLUTION Medicines builds upon the vision of the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute, who invented a transformative method for synthesizing original compound... s that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive license agreement with the University of Illinois to practice and expand this technology. REVOLUTION Medicines’ approach is a rapid, standardized and powerful process for assembling simple “chemical building blocks” into refined natural product-like structures. These optimized compounds have significant potential as best-in-class drug candidates.
REVOLUTION MEDICINES
Social Links:
Industry:
Health Care Life Science Medical
Founded:
2015-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.revmed.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
751.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon IPv6 Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API Microsoft Java EE
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-17 | Warp Drive Bio | Warp Drive Bio acquired by Revolution Medicines | N/A |
Investors List
Nextech Invest
Nextech Invest investment in Series C - Revolution Medicines
Boxer Capital
Boxer Capital investment in Series C - Revolution Medicines
Schroder Adveq
Schroder Adveq investment in Series C - Revolution Medicines
Cormorant Capital
Cormorant Capital investment in Series C - Revolution Medicines
Casdin Capital
Casdin Capital investment in Series C - Revolution Medicines
Vivo Capital
Vivo Capital investment in Series C - Revolution Medicines
Biotechnology Value Fund
Biotechnology Value Fund investment in Series C - Revolution Medicines
Deerfield Capital Management
Deerfield Capital Management investment in Series C - Revolution Medicines
Third Rock Ventures
Third Rock Ventures investment in Series C - Revolution Medicines
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Revolution Medicines
Official Site Inspections
http://www.revmed.com Semrush global rank: 1.6 M Semrush visits lastest month: 15.9 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Revolution Medicines"
Revolution Medicines
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our …See details»
Investor Relations | Revolution Medicines
The Investor Relations website contains information about Revolution Medicines's business for stockholders, potential investors, and financial analysts.See details»
Careers - Revolution Medicines
RevMed aims to make an impact in our community and within the biotech and medical communities. We partner with local and national non-profit organizations to support cancer patients, and to expand opportunities for under-represented …See details»
Revolution Medicines - Overview, News & Similar companies
Aug 7, 2024 · Revolution Medicines contact info: Phone number: (650) 481-6801 Website: www.revmed.com What does Revolution Medicines do? Revolution Medicines is a clinical …See details»
Revolution Medicines, Inc. (RVMD) - Yahoo Finance
See the company profile for Revolution Medicines, Inc. (RVMD) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Revolution Medicines to Present New Clinical Data at Major …
Oct 4, 2023 · Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D pipeline comprises RAS …See details»
Revolution Medicines to Deliver Multiple Presentations at the …
Mar 28, 2024 · About Revolution Medicines, Inc. Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D …See details»
Robert Nichols - VP, Corporate Development at REVOLUTION
Bob joined Revolution Medicines at the founding of the company and has made significant contributions to the company’s pipeline, particularly development of its unique RAS (ON) …See details»
Revolution Medicines Presents Updated Data from RMC-6236
Oct 23, 2024 · Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D pipeline comprises RAS …See details»
About – Revolution Medicines
We are Revolutionaries –passionate in our singular pursuit of discovering, developing and delivering innovative targeted therapies for patients living with RAS-addicted cancer. At Revolution Medicines, we believe in challenging the …See details»
Revolution Medicines to Provide Update on RMC-6236 Pancreatic …
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for …See details»
Science - Revolution Medicines
Revolution Medicines has built a deep pipeline to enable the discovery and development and delivery of innovative targeted therapies to patients in need of new therapeutic options.See details»
Revolution Medicines Presents Updated Data from RMC-6236 …
REDWOOD CITY, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS …See details»
Revolution Medicines Highlights Slate of Diverse Board of …
REDWOOD CITY, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing …See details»
RevMed - Crunchbase Company Profile & Funding
RevMed is a medical supply and equipment marketplace allowing hospitals and surgery centers buy and sell to one another. Our platform is designed to help healthcare professionals save …See details»
CRAN: Package VICatMix
A variational Bayesian finite mixture model for the clustering of categorical data, and can implement variable selection and semi-supervised outcome guiding if desired. Incorporates an …See details»
Revolution Medicines Reports Third Quarter Financial Results and …
REDWOOD CITY, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company developing targeted drugs to …See details»
RevMED - World Scientific Publishing Co Pte Ltd
RevMED teaches students how to interpret clinical cases by presenting key details of the history and examination of a patient and making them choose between five plausible options.See details»
RMC-6236, a Novel, First in Class, Tri-complex RASMULTI Inhibitor ...
8 CANCER Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS Christopher J. Schulze1†, Kyle J. Seamon1†, Yulei Zhao2†, Yu C. Yang1, Jim Cregg3, …See details»
Press Release - Revolution Medicines
Oct 13, 2023 · Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary evidence of anti-tumor activity …See details»